| |
|
|
|
Altimmune Inc.  
|
|
12.94 -0.24 (-0.02%) |
03-05 16:00 |
|
Open: |
13.808 |
Pre close: |
13.18 |
Target:
|
22.97 
|
|
High: |
13.808 |
Low: |
11.66 |
Resistance:
|
19.66
24.61
|
|
Volume: |
1,758,280 |
Market Cap: |
481M |
Support:
|
11.66
9.70
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
14.53
|
MACD |
MACD(12,26):
|
-0.69 |
|
MA(20): |
19.03 |
Signal(12,26,9): |
0.43 |
|
MA(100): |
13.74  |
Stochastic Oscillator |
%K(14,3):
|
6.95 |
|
MA(250): |
12.56 |
%D(3): |
5.64 |
|
Average Volume(K) |
3-Month: |
173964
|
52-Week |
High:
|
35.10 |
|
10-Days: |
162799 |
Low: |
2.50 |
|
RSI |
RSI(14):
|
34.35 |
Change(%): |
309.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.910 |
Return on Equity (ttm) |
-36.1 |
Shares Out. (M) |
37.15 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-16.1 |
Shares Float (M) |
29.20 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
6.51 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
301.7 |
% Held by Institutions |
67.29 |
|
Forward EPS |
-1.600 |
Gross Profit (p.s.) |
-0.682 |
Shares Short (K) |
2520 |
|
Book Value (p.s.) |
6.110 |
EBITDA (p.s.) |
-1.029 |
P/E |
-6.77 |
|
Sales Per Share |
0.220 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.12 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-34.44 |
P/S |
58.70 |
|
Operating Margin |
-470.78 |
Levered Free Cash Flow
(M) |
-25.74 |
P/CF |
-13.96 |
|
|
|
|
|
|
